MedTrace Logo

Vitamin K2 and Muscle Weakness in Type 2 Diabetes

NCT05375630 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-07-28

No results posted yet for this study

Summary

The aim of the current study is to determine the effects of vitamin K2 supplementation on muscle size and function in adults with muscle weakness and type 2 diabetes.

Conditions

  • Diabete Type 2

Interventions

DIETARY_SUPPLEMENT

Placebo

Placebo

DIETARY_SUPPLEMENT

Vitamin K2

Vitamin K2

Sponsors & Collaborators

  • Kappa Bioscience

    collaborator UNKNOWN

  • Dasman Diabetes Institute

    lead OTHER

Principal Investigators

  • Ebaa AlOzairi · Dasman Diabetes Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • Kuwait

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05375630 on ClinicalTrials.gov